Your session is about to expire
← Back to Search
Social media-based education, counseling, and support for Smoking Cessation
N/A
Waitlist Available
Led By Gary Humfleet, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Daily smoker
Self-identify as sexual and/or gender minority
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 to 6 months
Awards & highlights
Study Summary
This study is evaluating whether a social media-based smoking cessation program may help individuals quit smoking.
Eligible Conditions
- Smoking Cessation
- Smoking/Cigarette Smoking
- Tobacco Use
- Nicotine Addiction
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 to 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Participants With Reported 7-day Biochemically Verified Abstinence at 3 Months
Number of Participants With Reported 7-day Biochemically Verified Abstinence at 6 Months
Secondary outcome measures
Duration of Active Participation
Frequency of participation in live group sessions
Frequency of social media posts
+2 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Pride Posts PlusExperimental Treatment3 Interventions
This six month intervention will include all elements of the Pride Posts arm. In addition, the intervention will include gamification, gaming elements designed to encourage participation in the program and behavior change. Participants will also have access to up to six months of nicotine replacement therapy (patch + gum/lozenge). Dosage will be based manufacturer's recommendations which are based on self-reported smoking behaviors.
Group II: Pride PostsExperimental Treatment2 Interventions
This six month intervention will be conducted on the Facebook platform. Participants will receive regular social media posts tailored to the sexual and gender minority communities (LGBTQ+). Weekly live sessions with a tobacco expert will be available. Participants will also have access to up to six months of nicotine replacement therapy (patch + gum/lozenge). Dosage will be based manufacturer's recommendations which are based on self-reported smoking behaviors.
Group III: Usual Care ConditionActive Control1 Intervention
Participants in this arm will be provided with a referral to smokefree.gov, a federally-funded website which provides support and digital-based interventions to assist in smoking cessation activities. Participants will also have access to up to six months of nicotine replacement therapy (patch + gum/lozenge). Dosage will be based manufacturer's recommendations which are based on self-reported smoking behaviors.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Social media-based education, counseling, and support
2020
N/A
~130
Find a Location
Who is running the clinical trial?
Tobacco Related Disease Research ProgramOTHER
25 Previous Clinical Trials
20,497 Total Patients Enrolled
University of California, San FranciscoLead Sponsor
2,493 Previous Clinical Trials
11,931,677 Total Patients Enrolled
Gary Humfleet, PhDPrincipal InvestigatorUniversity of California, San Francisco
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
University of California, San Francisco
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger